Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1186/s12882-021-02552-2
10.1186/s12882-021-02552-2 · External reference
10.1007/978-981-13-8871-2_1
10.1007/978-981-13-8871-2_1 · External reference
Chronic kidney disease and emotional-behavioral disorders in adolescents
10.14238/pi59.6.2019.325-30 · 2019 · External reference
Unresolved reference
External reference
Prevention of pediatric chronic kidney disease
10.15406/unoaj.2020.08.00293 · 2020 · External reference
Unresolved reference
External reference
Steroid-resistant nephrotic syndrome: past and current perspectives
2017 · External reference
10.1159/000500925
10.1159/000500925 · External reference
Unresolved reference
External reference
Relationship between plasma aldosterone levels and arterial stiffness parameters in hypertensive patients with subclinical vascular damage
2022 · External reference
Effects of ramipril on the aldosterone/renin ratio and the aldosterone/angiotensin II ratio in patients with primary aldosteronism
10.1161/hypertensionaha.120.14871 · 2020 · External reference
Aldosterone blockade in chronic kidney disease: can it improve outcome?
2010 · External reference
Hypertension in childhood nephrotic syndrome
2019 · External reference
10.1016/j.semnephrol.2018.02.009
10.1016/j.semnephrol.2018.02.009 · External reference
Quality of life in children with severe forms of idiopathic nephrotic syndrome in stable remission: a cross-sectional study
10.1111/apa.14912 · 2019 · External reference
The role of novel biomarkers in childhood idiopathic nephrotic syndrome: a narrative review of published evidence
10.2147/ijnrd.s131869 · 2017 · External reference
10.1093/ndt/gfx379
10.1093/ndt/gfx379 · External reference
10.1093/ajh/hpaa137
10.1093/ajh/hpaa137 · External reference
10.11604/pamj.2019.34.31.17885
10.11604/pamj.2019.34.31.17885 · External reference
Evaluation of carotid intima-media thickness in children with idiopathic nephrotic syndrome
2022 · External reference
10.2147/vhrm.s295868
10.2147/vhrm.s295868 · External reference
10.1161/circulationaha.120.046361
10.1161/circulationaha.120.046361 · External reference
Annual reports on hypertension research 2020
10.1038/s41440-021-00766-3 · 2022 · External reference
Pathophysiology and consequences of arterial stiffness in children with chronic kidney disease
10.1007/s00467-020-04732-y · 2021 · External reference
Review on inflammation markers in chronic kidney disease
2021 · External reference
Hyperuricemia and its related diseases: mechanisms and advances in therapy
10.1038/s41392-024-01916-y · 2024 · External reference
10.1002/14651858.cd007004.pub3
10.1002/14651858.cd007004.pub3 · External reference
Chronic kidney disease in children: recent update
10.2174/1874303x015080100117 · 2015 · External reference
10.1101/cshperspect.a016295
10.1101/cshperspect.a016295 · External reference
Interleukin 6 concentration elevation as a risk of carotid intima-media thickness in chronic kidney disease patients with dialysis
10.17392/1172-20 · 2020 · External reference
Risk factors associated with carotid intima-media thickness in pediatric nephrotic syndrome
10.30867/action.v9i4.2262 · 2024 · External reference
